Tango Therapeutics (TNGX)
(Delayed Data from NSDQ)
$6.53 USD
+0.49 (8.11%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $6.52 -0.01 (-0.15%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
TNGX 6.53 +0.49(8.11%)
Will TNGX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TNGX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TNGX
IGM Biosciences, Inc. (IGMS) Q2 Earnings and Revenues Surpass Estimates
Mirum Pharmaceuticals, Inc. (MIRM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
TNGX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Believe Tango Therapeutics (TNGX) Could Rally 61.46%: Here's is How to Trade
Tango Therapeutics, Inc. (TNGX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Does Tango Therapeutics (TNGX) Have the Potential to Rally 75.89% as Wall Street Analysts Expect?
Other News for TNGX
Tango Therapeutics management to meet with Cantor Fitzgerald
Tango Therapeutics management to meet with Cantor Fitzgerald
Tango Therapeutics management to meet with Cantor Fitzgerald
TNGX: Upcoming Meetings in San Francisco and Denver
Tango Therapeutics management to meet with Cantor Fitzgerald